Osaic Holdings
IBB icon

Osaic Holdings’s iShares Biotechnology ETF IBB Stock Holding History

Osaic Holdings’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.4M Buy
102,066
+7,035
+7% +$1.21M 0.02% 680
2026
Q1 		$16.1M Buy
95,031
+2,130
+2% +$364K 0.02% 664
2025
Q4 		$15.7M Sell
92,901
-3,162
-3% -$514K 0.02% 687
2025
Q3 		$13.5M Buy
96,063
+5,061
+6% +$691K 0.02% 831
2025
Q2 		$11.5M Sell
91,002
-334
-0.4% -$41K 0.02% 748
2025
Q1 		$11.7M Sell
91,336
-14,329
-14% -$1.94M 0.03% 618
2024
Q4 		$14M Sell
105,665
-673
-0.6% -$94.6K 0.03% 520
2024
Q3 		$15.5M Sell
106,338
-11,991
-10% -$1.74M 0.03% 504
2024
Q2 		$16.2M Sell
118,329
-41,844
-26% -$5.59M 0.04% 464
2024
Q1 		$22M Buy
160,173
+13,777
+9% +$1.88M 0.05% 376
2023
Q4 		$19.9M Sell
146,396
-61,540
-30% -$7.51M 0.03% 483
2023
Q3 		$25.4M Buy
207,936
+34,089
+20% +$4.34M 0.04% 459
2023
Q2 		$22.1M Buy
173,847
+9,757
+6% +$1.27M 0.04% 431
2023
Q1 		$21.2M Sell
164,090
-132,965
-45% -$17.4M 0.04% 431
2022
Q4 		$39M Buy
297,055
+123,753
+71% +$16M 0.08% 240
2022
Q3 		$20.3M Sell
173,302
-4,699
-3% -$584K 0.05% 375
2022
Q2 		$21M Sell
178,001
-32,007
-15% -$3.8M 0.05% 373
2022
Q1 		$28.3M Sell
210,008
-52,591
-20% -$6.85M 0.05% 327
2021
Q4 		$40.1M Buy
262,599
+39,121
+18% +$6.06M 0.08% 254
2021
Q3 		$36.1M Sell
223,478
-13,299
-6% -$2.24M 0.08% 248
2021
Q2 		$38.8M Sell
236,777
-38,873
-14% -$5.99M 0.08% 242
2021
Q1 		$41.5M Buy
275,650
+27,821
+11% +$4.42M 0.1% 207
2020
Q4 		$37.5M Sell
247,829
-3,066
-1% -$438K 0.1% 200
2020
Q3 		$34M Buy
250,895
+20,766
+9% +$2.82M 0.1% 202
2020
Q2 		$31.5M Sell
230,129
-167,756
-42% -$21.4M 0.11% 201
2020
Q1 		$15.8M Buy
+397,885
New +$45.8M 0.06% 272

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Osaic Holdings's IBB Position: Q2 2026 in Review

Osaic Holdings increased its iShares Biotechnology ETF (IBB) stake by 7.4% in Q2 2026, buying an estimated $1.21M and bringing the position to 102,066 shares worth $19.4M. The position accounts for 0.02% of the portfolio, ranked #680.

Osaic Holdings first reported a position in IBB in Q1 2020 and has held it in 26 quarters since. The position peaked at $41.5M in Q1 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Osaic Holdings held 102,066 shares of iShares Biotechnology ETF worth $19.4M as of Q2 2026.
  • Osaic Holdings bought 7,035 iShares Biotechnology ETF shares in Q2 2026, an estimated $1.21M.
  • iShares Biotechnology ETF made up 0.02% of Osaic Holdings's portfolio in Q2 2026, its #680 holding.
  • Osaic Holdings first reported a position in iShares Biotechnology ETF in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's iShares Biotechnology ETF position peaked at $41.5M in Q1 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.